Immediate Impact

53 standout
Sub-graph 1 of 21

Citing Papers

Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
2024 Standout
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
2 intermediate papers

Works of Todd Riehl being referenced

Real-world data (RWD) on tumor response (rwTR) in advanced non-small cell lung cancer (aNSCLC) patients receiving cancer immunotherapy and targeted therapies.
2018
Blood-based biomarkers for cancer immunotherapy: Tumor mutational burden in blood (bTMB) is associated with improved atezolizumab (atezo) efficacy in 2L+ NSCLC (POPLAR and OAK)
2017

Author Peers

Author Last Decade Papers Cites
Todd Riehl 424 282 178 281 28 815
Lan L. Gellert 274 188 211 402 30 944
John Frye 284 173 92 221 24 744
Mitsuyo Yoshihara 292 270 159 336 36 854
CL Arteaga 538 312 174 427 27 936
Inga Grünewald 437 315 98 297 36 918
Matteo Trucco 311 376 156 347 36 958
Yu Jin Kim 293 318 201 318 38 936
Fabian Zohren 274 634 213 317 44 982
L. Austin Doyle 403 197 107 329 33 905
Silvia Rita Vitale 246 177 321 415 46 933

All Works

Loading papers...

Rankless by CCL
2026